Essentials• It is unknown if a male or female thrombotic family history influences risk in
female relatives.• We assessed thrombotic risk in female relatives of male and female …

Although the use of oral contraceptives has been frequently associated with an increased
risk of thromboembolic events, definitive prothrombotic mechanisms have not so far been …

Aims The interaction between the R506Q mutation of factor V and the G20210A mutation of
prothrombin with oral contraceptives on venous thromboembolism was evaluated. Methods …

SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism:
an update: no. 252, December 2010. - Abstract - Europe PMC Sign in | Create an account …

Second-generation COCs should be the first choice when prescribing hormonal
contraception. In patients with a history of VTE and/or a known thrombophilic defect, COCs …

Since the introduction of oral contraceptives, their use has been associated with an
increased risk of both venous and arterial thrombosis. Pulmonary embolism, myocardial …

Previous reports and reviews indicate differences in effects of second and third generation
combined oral contraceptives (COCs) on haemostasis variables. This review analyses …

Estrogen-containing medication, prescribed either for contraception in women of
reproductive age or for prevention of cardiovascular events and osteoporosis as well as for …

Because use of combined oral contraceptives (COCs) confers some risk of venous
thromboembolism (VTE), there is concern that this effect may be greater among women with …

The risk of venous thromboembolism (VTE) varies throughout a woman's life and is
associated primarily with underlying hormonal exposure. Alteration in hemostatic …